Quince amends EIB credit facility; min cash balance reduced to EUR 5M for Q1 2026

Quince Therapeutics, Inc.

Minimum cash balance reduced from EUR 14.65M to EUR 5M for Jan-Mar 2026 period.
1% of 9% deferred interest converted to fixed rate, payable March 31, 2026.
Amendment dated September 25, 2025 under EIB Facility originally July 24, 2020.

item 1.01item 2.03

Source: SEC EDGAR

accession 0001193125-25-220722

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.